|
Volumn 72, Issue , 2014, Pages 35-45
|
Design, synthesis and anti-inflammatory evaluation of novel 5-benzylidene-3,4-dihalo-furan-2-one derivatives
|
Author keywords
3,4 Dihalo furan 2 one; Action mechanism; Anti inflammation; PPAR ; Synthesis
|
Indexed keywords
2 CHLORO 5 NITROBENZANILIDE;
3,4 DIBROMO 5 [3 ETHOXY 4 (2 (5 ETHYLPYRIDIN 2 YL) ETHOXY)BENZYLIDENE] FURAN 2(5H) ONE;
3,4 DIBROMO 5 [3 ETHOXY 4 (2 (PYRIDIN 2 YL)ETHOXY) BENZYLIDENE]FURAN 2(5H) ONE;
3,4 DIBROMO 5 [3 ETHOXY 4 (PYRIDIN 2 YLMETHOXY)BENZYLIDENE]FURAN 2(5H) ONE;
3,4 DIBROMO 5 [3 METHOXY 4 ((3,5,6 TRIMETHYLPYRAZIN 2 YL)METHOXY)BENZYLIDENE]FURAN 2(5H) ONE;
3,4 DIBROMO 5 [3 METHOXY 4 (2 (PYRIDIN 2 YL)ETHOXY) BENZYLIDENE]FURAN 2(5H) ONE;
3,4 DIBROMO 5 [3 METHOXY 4 (PYRIDIN 2 YLMETHOXY) BENZYLIDENE]FURAN 2(5H) ONE;
3,4 DIBROMO 5 [4 ((3,5,6 TRIMETHYLPYRAZIN 2 YL) METHOXY)BENZYLIDENE] FURAN 2(5H) ONE;
3,4 DIBROMO 5 [4 (2 (5 ETHYLPYRIDIN 2 YL)ETHOXY) 3 METHOXYBENZYLIDENE] FURAN 2(5H) ONE;
3,4 DIBROMO 5 [4 (2 (5 ETHYLPYRIDIN 2 YL)ETHOXY)BENZYLIDENE]FURAN 2(5H) ONE;
3,4 DIBROMO 5 [4 (2 (PYRIDIN 2 YL)ETHOXY)BENZYLIDENE] FURAN 2(5H) ONE;
3,4 DIBROMO 5 [4 (PYRIDIN 2 YLMETHOXY)BENZYLIDENE] FURAN 2(5H) ONE;
3,4 DICHLORO 5 [3 ETHOXY 4 (2 (PYRIDIN 2 YL)ETHOXY) BENZYLIDENE]FURAN 2(5H) ONE;
3,4 DICHLORO 5 [3 ETHOXY 4 (PYRIDIN 2 YLMETHOXY)BENZYLIDENE]FURAN 2(5H) ONE;
3,4 DICHLORO 5 [3 METHOXY 4 (2 (PYRIDIN 2 YL)ETHOXY) BENZYLIDENE]FURAN 2(5H) ONE;
3,4 DICHLORO 5 [3 METHOXY 4 (PYRIDIN 2 YLMETHOXY) BENZYLIDENE]FURAN 2(5H) ONE;
3,4 DICHLORO 5 [4 (2 (5 ETHYLPYRIDIN 2 YL)ETHOXY)BENZYLIDENE]FURAN 2(5H) ONE;
3,4 DICHLORO 5 [4 (2 (PYRIDIN 2 YL)ETHOXY)BENZYLIDENE] FURAN 2(5H) ONE;
3,4 DICHLORO 5 [4 (PYRIDIN 2 YLMETHOXY)BENZYLIDENE] FURAN 2(5H) ONE;
5 [3 ((3,5,6 TRIMETHYLPYRAZIN 2 YL)METHOXY)BENZYLIDENE]THIAZOLIDINE 2,4 DIONE;
5 [3 ETHOXY 4 ((3,5,6 TRIMETHYLPYRAZIN 2 YL)METHOXY) BENZYLIDENE] THIAZOLIDINE 2,4 DIONE;
5 [3 METHOXY 4 ((3,5,6 TRIMETHYLPYRAZIN 2 YL)METHOXY) BENZYLIDENE] THIAZOLIDINE 2,4 DIONE;
5 [4 ((3,5,6 TRIMETHYLPYRAZIN 2 YL)METHOXY)BENZYLIDENE] THIAZOLIDINE 2,4 DIONE;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
INDOMETACIN;
INTERLEUKIN 6;
MITOGEN ACTIVATED PROTEIN KINASE;
NITRIC OXIDE;
ROSIGLITAZONE;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
2-CHLORO-5-NITROBENZANILIDE;
ANILIDE;
BENZYLIDENE DERIVATIVE;
FURAN DERIVATIVE;
NONSTEROID ANTIINFLAMMATORY AGENT;
ANIMAL CELL;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
CARBON NUCLEAR MAGNETIC RESONANCE;
CONTROLLED STUDY;
DRUG BINDING SITE;
DRUG CYTOTOXICITY;
DRUG DESIGN;
DRUG SCREENING;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HYDROGEN BOND;
MASS SPECTROMETRY;
MEDIATOR;
MOLECULAR DOCKING;
MOUSE;
NONHUMAN;
PROTEIN PHOSPHORYLATION;
PROTON NUCLEAR MAGNETIC RESONANCE;
SIGNAL TRANSDUCTION;
STRUCTURE ACTIVITY RELATION;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
BIOSYNTHESIS;
CELL LINE;
CELL SURVIVAL;
CHEMICAL STRUCTURE;
CHEMISTRY;
METABOLISM;
SYNTHESIS;
ANILIDES;
ANIMALS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
BENZYLIDENE COMPOUNDS;
CELL LINE;
CELL SURVIVAL;
DRUG DESIGN;
FURANS;
INTERLEUKIN-6;
MICE;
MITOGEN-ACTIVATED PROTEIN KINASES;
MODELS, MOLECULAR;
MOLECULAR STRUCTURE;
NF-KAPPA B;
NITRIC OXIDE;
STRUCTURE-ACTIVITY RELATIONSHIP;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 84889965426
PISSN: 02235234
EISSN: 17683254
Source Type: Journal
DOI: 10.1016/j.ejmech.2013.10.074 Document Type: Article |
Times cited : (15)
|
References (53)
|